
Bcl-xS/L Antibody (4E19) is a mouse monoclonal IgG2a antibody that detects Bcl-xS/L in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and immunohistochemistry. Bcl-xS/L plays a crucial role in regulating apoptosis, acting as a pro-apoptotic member of the Bcl-2 family. Bcl-xS/L is primarily located in mitochondria, where anti-Bcl-xS/L antibody (4E19) can detect interactions with other Bcl-2 family members that modulate cell survival and death pathways. This localization allows Bcl-xS/L to directly influence mitochondrial membrane permeability, a key event in the apoptotic process. By promoting cytochrome c release from mitochondria, Bcl-xS/L facilitates caspase activation, which is essential for executing apoptosis. The balance between pro-apoptotic and anti-apoptotic signals, including those mediated by Bcl-xS/L and counterparts like Bcl-2, maintains cellular homeostasis and prevents uncontrolled cell proliferation that can lead to cancer. Bcl-xS/L monoclonal antibody (4E19) serves as a valuable tool for studying apoptosis and its implications in various diseases, including cancer and neurodegenerative disorders.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Bcl-xS/L Antibody (4E19) | sc-70417 | 200 µg/ml | $322.00 | |||
Bcl-xS/L Antibody (4E19): m-IgG Fc BP-HRP Bundle | sc-551950 | 200 µg Ab; 10 µg BP | $361.00 |